[Hyperammonaemic encephalopathy due to valproic acid in the neonatal period].
Jiménez-Parrilla
F
F
Pérez-Sánchez
A
A
Núñez-Solís
J M
JM
Madruga-Garrido
M
M
Losada-Martínez
A
A
D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D001928:Brain Diseases, Metabolic / Q000139:chemically induced*; D006801:Humans; D022124:Hyperammonemia / Q000139:chemically induced*; D007231:Infant, Newborn; D012640:Seizures / Q000188:drug therapy; D014635:Valproic Acid / Q000009:adverse effects* / Q000627:therapeutic use
D000927:Anticonvulsants; D014635:Valproic Acid